NSLI
CME icon

Nan Shan Life Insurance’s CME Group CME Stock Holding History

Nan Shan Life Insurance’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.3M Buy
+102,540
New +$30.5M 1.1% 32
2025
Q4 		– Sell
-164,720
Closed -$44.5M – 87
2025
Q3 		$44.5M Buy
164,720
+15,710
+11% +$4.27M 0.95% 31
2025
Q2 		$41.1M Buy
149,010
+120,454
+422% +$32.8M 0.91% 34
2025
Q1 		$7.58M Sell
28,556
-25,344
-47% -$6.25M 0.18% 87
2024
Q4 		$12.5M Buy
+53,900
New +$12.4M 0.3% 77
2024
Q3 		– Sell
-144,433
Closed -$28.4M – 101
2024
Q2 		$28.4M Hold
144,433
– – 0.67% 54
2024
Q1 		$31.1M Buy
144,433
+54,000
+60% +$11.3M 0.73% 53
2023
Q4 		$19M Buy
90,433
+70,433
+352% +$15M 0.46% 62
2023
Q3 		$4M Sell
20,000
-248,290
-93% -$49.4M 0.11% 85
2023
Q2 		$49.7M Hold
268,290
– – 1.2% 27
2023
Q1 		$51.4M Buy
+268,290
New +$48.5M 1.22% 25
2022
Q1 		– Sell
-120,000
Closed -$27.4M – 90
2021
Q4 		$27.4M Hold
120,000
– – 0.42% 67
2021
Q3 		$23.2M Sell
120,000
-62,000
-34% -$12.6M 0.39% 69
2021
Q2 		$38.7M Sell
182,000
-90,785
-33% -$19.2M 0.66% 57
2021
Q1 		$55.7M Buy
272,785
+174,785
+178% +$34.4M 1.08% 27
2020
Q4 		$17.8M Sell
98,000
-30,000
-23% -$5.1M 0.37% 78
2020
Q3 		$21.4M Sell
128,000
-9,821
-7% -$1.65M 0.56% 52
2020
Q2 		$22.4M Sell
137,821
-15,179
-10% -$2.72M 0.68% 48
2020
Q1 		$26.5M Buy
153,000
+50,000
+49% +$9.95M 0.97% 34
2019
Q4 		$20.7M Buy
103,000
+98,888
+2,405% +$20.3M 0.64% 40
2019
Q3 		$869K Buy
4,112
+1,141
+38% +$238K 0.02% 85
2019
Q2 		$577K Sell
2,971
-2,650
-47% -$489K 0.01% 91
2019
Q1 		$925K Buy
+5,621
New +$994K 0.02% 102

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nan Shan Life Insurance's CME Position: Q1 2026 in Review

Nan Shan Life Insurance opened a new position in CME Group (CME) in Q1 2026: 102,540 shares worth $30.3M. The stake represents 1.1% of the portfolio and ranks #32 among its holdings. This is a return to the name: Nan Shan Life Insurance previously reported a position in CME as recently as Q3 2025.

Nan Shan Life Insurance first reported a position in CME in Q1 2019 and has held it in 23 quarters since. The position peaked at $55.7M in Q1 2021. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Nan Shan Life Insurance held 102,540 shares of CME Group worth $30.3M as of Q1 2026.
  • CME Group was a new Nan Shan Life Insurance position in Q1 2026.
  • CME Group made up 1.1% of Nan Shan Life Insurance's portfolio in Q1 2026, its #32 holding.
  • Nan Shan Life Insurance first reported a position in CME Group in Q1 2019 and has held it in 23 quarters since.
  • Nan Shan Life Insurance's CME Group position peaked at $55.7M in Q1 2021.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Nan Shan Life Insurance's 13F filing for Q1 2026, filed 14 May 2026.